Piper Sandler analyst Michael Lavery maintains Tyson Foods (NYSE:TSN) with a Underweight and lowers the price target from $85 to $79.
Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It ‘Extortion’
Merck & Co Inc (NYSE: MRK) has reportedly filed a lawsuit against the U.S. government to halt implementing the Medicare drug price negotiation program outlined in the Inflation Reduction Act (IRA).